Funding for this research was provided by:
Global Innovation Fund (01122015)
Ajinomoto Co. Inc (01122013)
The Japan International Cooperation Agency (OS-JR-17047)
Received: 6 September 2018
Accepted: 17 June 2019
First Online: 24 June 2019
Ethics approval and consent to participate
: Adherence to ethical principles has been extensively described elsewhere [CitationRef removed]. Briefly, the study was approved on 23rd March 2015 by the National Ethics Committee of the Malawi Ministry of Health and from Institutional Review Board of Ajinomoto Co., Inc., (Ref no. 2014–021) and was registered on 15th April 2015 in the Pan African Clinical Trial Registry (PACTR201505001101224) prior to starting recruitment.Participation was voluntary and the carer signing of the consent form confirmed the enrolment. The study was carried out in accordance with the declaration of Helsinki and adheres to CONSORT guidelines.
: Not applicable.
: Valid Nutrition and Ajinomoto Co. Inc. designed and produced the SMS-RUTFs. PA is an employee of Valid Nutrition and HM is an employee of Ajinomoto Co. Inc. SC is the unpaid director of Valid Nutrition and a director of Valid International Ltd. Valid International Ltd. is the sister company of Valid Nutrition, and PB and KS are Valid International employees. All other authors had no conflict of interest. Valid Nutrition administered the study grant. Valid Nutrition and Valid International researchers participated in the study design, implementation, and interpretation of the results. Apart from contributing HM’s expertise, Ajinomoto Co. Inc. had no role in the study design, data collection, analysis and interpretation, or the decision to publish the findings.